definiens: means any Patent, other than a Joint Patent or CRISPRProgram Patent that ( a ) CRISPR or any of its Affiliates Control as of the Effective Date or4 [ * * * ] INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HASBEEN REQUESTED . ALL SUCH OMITTED MATERIAL HAS BEEN FILED WITH THE SECURITIES ANDEXCHANGE COMMISSION PURSUANT TO RULE 24b-2 PROMULGATED UNDER THE SECURITIES EXCHANGEACT OF 1934, AS AMENDED that comes into the Control of CRISPR or any of its Affiliates during the Agreement Termand ( b ) claims or discloses any CRISPR Background Know - How or is otherwisereasonably necessary or reasonably useful for the Research, Development, Manufacture, Commercialization or use of Product Candidates or Products